Skip to main content
logo
Arovella Therapeutics Limited (ASX:ALA)
Australia flag Australia · Delayed Price · Currency is AUD
0.0650
+0.0010 (1.56%)
Aug 21, 2026, 3:57 PM AEST

Arovella Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
4.34.33.441.951.450.3
Revenue Growth
33.91%24.94%76.22%34.20%391.75%-70.11%
Gross Profit
4.34.33.441.951.250.09
Operating Income
-6.92-6.92-7.9-8.88-8.63-7.6
Net Income
-6.92-6.92-7.51-8.75-10.18-8.62
Earnings Per Share
-0.01-0.01-0.01-0.01-0.01-0.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
14.3514.3520.8812.715.186.07
Total Debt
-----0.14
Net Cash (Debt)
14.3514.3520.8812.715.185.93
Net Cash Growth
-25.89%-31.25%64.20%145.67%-12.67%-10.72%
Net Cash Per Share
0.010.010.020.010.010.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-6.91-6.91-6.93-6.91-6.4-6.27
Capital Expenditures
-0.04-0.04-0.41-0.13-0-0.04
Free Cash Flow
-6.95-6.95-7.34-7.04-6.4-6.3
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%86.01%30.00%
Operating Margin
-160.92%-160.92%-229.61%-454.69%-593.40%-2568.01%
Pretax Margin
-160.92%-160.92%-218.28%-448.03%-699.91%-2914.23%
Profit Margin
-160.92%-160.92%-218.28%-448.03%-699.91%-2914.23%
FCF Margin
-161.59%-161.59%-213.45%-360.80%-439.99%-2130.85%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
18.2817.4434.4475.3429.2152.08